These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7658751)

  • 1. Salmeterol.
    Johnson M
    Med Res Rev; 1995 May; 15(3):225-57. PubMed ID: 7658751
    [No Abstract]   [Full Text] [Related]  

  • 2. Salmeterol: a long acting bronchodilator.
    Bhadoria DP; Bhadoria P
    J Postgrad Med; 1995; 41(1):24-6. PubMed ID: 10740700
    [No Abstract]   [Full Text] [Related]  

  • 3. Xinafoic acid is not a solvent for salmeterol.
    Johnson M
    Chest; 1999 Oct; 116(4):1138. PubMed ID: 10531587
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-acting beta 2-agonists.
    Tattersfield AE
    Clin Exp Allergy; 1992 Jun; 22(6):600-5. PubMed ID: 1356604
    [No Abstract]   [Full Text] [Related]  

  • 5. Salmeterol for the prevention of high-altitude pulmonary edema.
    Bärtsch P; Mairbäurl H
    N Engl J Med; 2002 Oct; 347(16):1282-5; author reply 1282-5. PubMed ID: 12397659
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacology of salmeterol.
    Johnson M; Butchers PR; Coleman RA; Nials AT; Strong P; Sumner MJ; Vardey CJ; Whelan CJ
    Life Sci; 1993; 52(26):2131-43. PubMed ID: 8099695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effect of salmeterol and salbutamol in normal subjects.
    Spring J; Clague J; Ind PW
    Br J Clin Pharmacol; 1992 Feb; 33(2):139-41. PubMed ID: 1348000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
    Johnson M; Rennard S
    Chest; 2001 Jul; 120(1):258-70. PubMed ID: 11451847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of NO-producing function of the lungs with salmeterol.
    Eliseeva EV; Romanova NA; Maistrovskaya YV
    Bull Exp Biol Med; 2001 Jul; 132(1):709-12. PubMed ID: 11687859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of long-acting beta-receptor agonists.
    Tattersfield AE
    Life Sci; 1993; 52(26):2161-9. PubMed ID: 8099697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol: a novel, long-acting beta 2-agonist.
    Meyer JM; Wenzel CL; Kradjan WA
    Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthma.
    Korosec M; Novak RD; Myers E; Skowronski M; McFadden ER
    Am J Med; 1999 Sep; 107(3):209-13. PubMed ID: 10492312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the tolerance to the bronchoprotective effect of salmeterol clinically relevant?
    Nathan RA
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):1-3; discussion 4. PubMed ID: 9475559
    [No Abstract]   [Full Text] [Related]  

  • 15. Salmeterol.
    Ind PW
    Br J Hosp Med; 1990 Nov; 44(5):343-4. PubMed ID: 1980426
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-isomer beta-agonists.
    Handley DA
    Pharmacotherapy; 2001 Mar; 21(3 Pt 2):21S-27S. PubMed ID: 11253864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterol.
    Szczuka A; Wennerberg M; Packeu A; Vauquelin G
    Br J Pharmacol; 2009 Sep; 158(1):183-94. PubMed ID: 19594756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
    Lindén A; Rabe KF; Löfdahl CG
    Lung; 1996; 174(1):1-22. PubMed ID: 8746998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of salmeterol.
    Cazzola M; Testi R; Matera MG
    Clin Pharmacokinet; 2002; 41(1):19-30. PubMed ID: 11825095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of the persistent action of salmeterol: what is the current position?
    Coleman RA
    Br J Pharmacol; 2009 Sep; 158(1):180-2. PubMed ID: 19719780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.